Efficacy and safety of eculizumab in patients with neuromyelitis optica spectrum disorder previously treated with rituximab: findings from PREVENT

被引：0

作者：

Levy, M. ^{[1
,2
]}

Berthele, A. ^{[3
]}

Kim, H. J. ^{[4
]}

Fujihara, K. ^{[5
]}

Nakashima, I. ^{[5
]}

Oreja-Guevara, C. ^{[6
]}

Palace, J. ^{[7
]}

Pittock, S. ^{[8
]}

Terzi, M. ^{[9
]}

Totolyan, N. ^{[10
]}

Viswanathan, S. ^{[11
]}

Wang, K. -C. ^{[12
]}

Pace, A. ^{[13
]}

Yountz, M. ^{[13
]}

Lawson, D. ^{[13
]}

Laudon-Meyer, E. ^{[13
]}

Wingerchuk, D. ^{[14
]}

机构：

[1] Massachusetts Gen Hosp, Boston, MA 02114 USA

[2] Harvard Med Sch, Boston, MA 02115 USA

[3] Tech Univ Munich, Klinikum Rechts Isar, Munich, Germany

[4] Natl Canc Ctr, Res Inst & Hosp, Goyang, South Korea

[5] Tohoku Univ, Sendai, Miyagi, Japan

[6] Hosp Univ Clin San Carlos, Madrid, Spain

[7] John Radcliffe Hosp, Oxford, England

[8] Mayo Clin, Rochester, MN USA

[9] Ondokuz Mayis Univ, Samsun, Turkey

[10] First Pavlov State Med Univ St Petersburg, St Petersburg, Russia

[11] Kuala Lumpur Hosp, Kuala Lumpur, Malaysia

[12] Cheng Hsin Gen Hosp, Taipei, Taiwan

[13] Alexion Pharmaceut, Boston, MA USA

[14] Mayo Clin, Scottsdale, AZ USA

来源：

MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

FC01.02

引用

下载

页码：1 / 2

页数：2

共 50 条

[1] Efficacy and Safety of Eculizumab in Patients with Neuromyelitis Optica Spectrum Disorder Previously Treated with Rituximab: Findings from the Phase 3 PREVENT Study
Levy, Michael
Berthele, Achim
Kim, Ho Jin
Fujihara, Kazuo
Nakashima, Ichiro
Oreja-Guevara, Celia
Palace, Jacqueline
Pittock, Sean
Terzi, Murat
Totolyan, Natalia
Viswanathan, Shanthi
Wang, Kai-Chen
Pace, Amy
Yountz, Marcus
Lawson, Diane
Meyer, Eva-Laudon
Wingerchuk, Dean
NEUROLOGY, 2020, 94 (15)
[2] Safety and efficacy of rituximab in neuromyelitis optica spectrum disorder
Radaelli, M.
Moiola, L.
Privitera, D.
Rodegher, M.
Colombo, B.
Barcella, V.
Sangalli, F.
Esposito, F.
Comi, G.
Martinelli, V.
JOURNAL OF NEUROLOGY, 2011, 258 : 261 - 262
[3] Long-term Safety and Efficacy of Eculizumab in Neuromyelitis Optica Spectrum Disorder
Wingerchuk, Dean M.
Pittock, Sean J.
Berthele, Achim
Fujihara, Kazuo
Kim, Ho Jin
Levy, Michael
Palace, Jacqueline
Nakashima, Ichiro
Terzi, Murat
Totolyan, Natalia
Viswanathan, Shanthi
Wang, Kai-Chen
Allen, Kerstin
Fujita, Kenji P.
Yountz, Marcus
Armstrong, Roisin
NEUROLOGY, 2020, 94 (15)
[4] Efficacy and safety of rituximab in multiple sclerosis and neuromyelitis optica spectrum disorder
Tatchaporn Ongphichetmetha
Jiraporn Jitprapaikulsan
Sasitorn Siritho
Natthapon Rattanathamsakul
Thammachet Detweeratham
Naraporn Prayoonwiwat
Scientific Reports, 14
[5] Efficacy and safety of rituximab in multiple sclerosis and neuromyelitis optica spectrum disorder
Ongphichetmetha, Tatchaporn
Jitprapaikulsan, Jiraporn
Siritho, Sasitorn
Rattanathamsakul, Natthapon
Detweeratham, Thammachet
Prayoonwiwat, Naraporn
SCIENTIFIC REPORTS, 2024, 14 (01)
[6] Eculizumab in the treatment of neuromyelitis optica spectrum disorder
Nabizadeh, Fardin
Moghadasi, Abdorreza Naser
CURRENT JOURNAL OF NEUROLOGY, 2023, 22 (02): : 140 - 143
[7] Eculizumab Pharmacokinetics and Pharmacodynamics in Patients With Neuromyelitis Optica Spectrum Disorder
Singh, Pratap
Gao, Xiang
Kleijn, Huub Jan
Bellanti, Francesco
Pelto, Ryan
FRONTIERS IN NEUROLOGY, 2021, 12
[8] Eculizumab in the treatment of neuromyelitis optica spectrum disorder
Giglhuber, Katrin
Berthele, Achim
IMMUNOTHERAPY, 2020, 12 (14) : 1053 - 1066
[9] Long-term efficacy and safety of rituximab in the treatment of neuromyelitis Optica Spectrum disorder
Hayes, Michael T. G.
Adam, Robert J.
McCombe, Pamela A.
Walsh, Michael
Blum, Stefan
MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2024, 10 (02)
[10] Safety and efficacy of rtuximab in patients affected by neuromyelitis optica spectrum disorder
Radaelli, M.
Moiola, L.
Rodegher, M.
Colombo, B.
Privitera, D.
Sangalli, F.
Barcella, V.
Martinelli, V.
Comi, G.
MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S290 - S291

← 1 2 3 4 5 →